Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.

Authors: Wenzl FA, Wang P, Kahles F, Beck KR, Giannitsis E, Obeid S, Bruno F, Li XS, Nanchen D, Liberale L, Smolle MA, Schweiger V, Klingenberg R, Manka R, Stähli BE, Templin C, König M, Yuan J, Yildirim M, Lehrke M, von Eckardstein A, Marx N, Mach F, Räber L, Katus HA, Steinhagen-Thiessen E, Demuth I, Deanfield J, Libby P, Hazen SL, Haghikia A, Landmesser U, Bäckhed F, Lüscher TF, SPUM-ACS, CLEVER-ACS, Heidelberg II-ACS and LipidCardio Investigators

Journal: European heart journal